Program / Timetable

Timetable

Timetable

Program

Annual President Invited Lecture

• Discovery and Development of COVID-19 Vaccines and Therapeutics

Special Lecture

• Deciphering the mistery of sleep: toward the molecular substrate for ”sleepiness”

• Cognitive performance pioneered by the co-creation of brain and AI

• Small fish models reveal the hidden mechanisms of aging and cancer

• Forefront of toxicity research by chromosome engineering technology

• Narratives for Drug Discovery in Academia

• A long journey of the Japanese fancy mice

• Basic toxicology of PFAS and its environmental problems in Japan

• Environmental problems of Perfluoroalkyl substances in Japan and their basic toxicology

Educational Lecture

• Human sex chromosomes and environmental conditions

• NRF2-addicted Cancer: From Classical Experimental Animal Models toward Diagnosis and Treatment

• Toxicity of addictive substances to the nervous system: including effects in children and during development.

Annual President Lecture　

• Advances in toxicology from the perspective of paradigm shifts in life sciences.

Frontier Seminar

• Primary Study of Toxicity Assessment Using Protein Structure Prediction by AlphaFold2

Symposium

• Current Situation and Prospects of Biomarker-based Strategies in Drug Development
• ToxicoEpigenetics as a leading edge of Toxicomics and the role of AI to its deployment.
• Biometals Specialty Section Symposium - 50 years of metal toxicology and expectations for the next 50 years
• Microglial Toxicology
• Current status and future perspectives of New Approach Methodologies (NAMs) in Next Generation Risk Assessment (NGRA)
• Approach to Safety assessment of Extractables and Leachables in pharmaceutical products
• Current status and perspective for Cutting-Edge Technologies for accelarating the research of toxicological mechanism.
• Elucidation and Detection of Novel Toxicity Mechanisms via Chemical Adduct Formation
• Cardiovascular adaptive homeostasis and dysregulation: toward drug toxicity assessment
• DX as practiced in the pharmaceutical industry: toxicology research/non-clinical areas
• New challenges of developmental neurobehavioral toxicity
• New era of education and research in forensic toxicology
• Concepts of risk for developmental toxicity via male reproduction in pharmaceuticals
• Developments in Research on Carcinogenesis Caused by Disruption of Cell Cycle Regulation
• Current issues of Non-clinical Studies for Drug Development: Consideration from the View of Pharmaceutical Companies and CROs
• Approaches for assessment of environmental exposures and immunotoxicity during susceptible life stages
• Current trends and research in genome instability
• Current Application and Future Prospects of Data Science in Toxicology / Safety Evaluation
• JCA-JSOT Joint Symposium: Anticancer drug development and toxicology
• What is Immunotoxicology? -Toxicological Effects on "Immune Cells at Work", Activation or Suppression-
• Gender differences in adverse drug reactions
• JSTP-JSOT Joint Symposium: Species difference in toxicity of chemicals from the viewpoint of toxicologic pathology
• The developmental mechanism regulated by signal interaction and the prediction of developmental toxicity via their disruption.
• Seminar for researchers leading toward a new era:Application of Electromagnetic Wave Technology Research to Toxicology -Seeing the Invisible-
• Species differences in detoxification
• Basic chmestry of fluorine, its presemt and futture prospects on drug development and toxicology of poly fluorinated organic compounds
• A New Framework for Carcinogenicity Studies-Implementation of WoE approach
• Towards interdisciplinary toxicology: expansion to medical science
• Career development support program for toxicologists: Education and development of human resources in digital age
• Biometals Specialty Section Symposium -Reproductive Toxicity of Metals-
• Epigenetics Innovations
  -A wide range of research from model animals to human diseases-
• Frontiers of Exosome Research
• Current status and future perspectives of microphysiological system (MPS) technology: Toward the application to drug and chemical development and regulatory use
• JSEDR-JSOT Joint Symposium: Children's Brain Toxicology
  - Xenobiotics-modulated higher brain functions and its molecular mechanisms -
• Recent trends in basic study and clinical application of the cutting-edge technology in clinical toxicology and/or toxicology
• Environmental pollution and its toxic effects occurring "now" in developing countries

Workshop

• Toxicology education in the field of veterinary medicine
• Target Safety Assessment (TSA) - Towards effective selection of drug candidate compounds -
• Shin-toxicity questionnaire - How to select animal species in toxicity studies

Open Symposium

• Safety evaluation and future of organoids toward chemicals and food applications
• Safety evaluation and its perspectives in anti viral drugs
• New Approaches to Evaluate Bile Excretion and the Risk of Cholestasis for Human Prediction
• Discovery toxicology strategy for New modality

Evening Forum

• Toxicomics Forum